These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 19634350)

  • 1. Formulation optimization of long-acting depot injection of aripiprazole by using D-optimal mixture design.
    Nahata T; Saini TR
    PDA J Pharm Sci Technol; 2009; 63(2):113-22. PubMed ID: 19634350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-optimal designing and optimization of long acting microsphere-based injectable formulation of aripiprazole.
    Nahata T; Saini TR
    Drug Dev Ind Pharm; 2008 Jul; 34(7):668-75. PubMed ID: 18608461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole.
    Potkin SG; Raoufinia A; Mallikaarjun S; Bricmont P; Peters-Strickland T; Kasper W; Baker RA; Eramo A; Sanchez R; McQuade R
    Curr Med Res Opin; 2013 Oct; 29(10):1241-51. PubMed ID: 23822566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aripiprazole intramuscular depot as maintenance treatment in patients with schizophrenia: a 52-week, multicenter, randomized, double-blind, placebo-controlled study.
    Kane JM; Sanchez R; Perry PP; Jin N; Johnson BR; Forbes RA; McQuade RD; Carson WH; Fleischhacker WW
    J Clin Psychiatry; 2012 May; 73(5):617-24. PubMed ID: 22697189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation, Optimization and Physicochemical Characterization of Aripiprazole Loaded Nano-porous in situ Forming Implant.
    Hedayati A; Yazdi SG; Dehghankelishadi P; Javan NB; Akbari H; Dorkoosh FA
    Pharm Nanotechnol; 2017; 5(2):138-147. PubMed ID: 28530539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aripiprazole.
    Ardiana F; Lestari ML; Indrayanto G
    Profiles Drug Subst Excip Relat Methodol; 2013; 38():35-85. PubMed ID: 23668402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of encapsulation efficiency of nanoemulsion-containing aripiprazole for the treatment of schizophrenia using mixture experimental design.
    Masoumi HR; Basri M; Samiun WS; Izadiyan Z; Lim CJ
    Int J Nanomedicine; 2015; 10():6469-76. PubMed ID: 26508853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation.
    Su ZX; Shi YN; Teng LS; Li X; Wang LX; Meng QF; Teng LR; Li YX
    Pharm Dev Technol; 2011 Aug; 16(4):377-84. PubMed ID: 20370594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics and safety of aripiprazole long-acting injection, following multiple deltoid administrations in schizophrenia patients in Japan].
    Ishigooka J; Noda T; Nishiyama K; Tamaru N; Shima T; Yamasaki Y; Tadori Y
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2016 Jun; 36(3):63-8. PubMed ID: 27506082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced dissolution and oral bioavailability of aripiprazole nanosuspensions prepared by nanoprecipitation/homogenization based on acid-base neutralization.
    Xu Y; Liu X; Lian R; Zheng S; Yin Z; Lu Y; Wu W
    Int J Pharm; 2012 Nov; 438(1-2):287-95. PubMed ID: 22989976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative bioavailability and safety of aripiprazole lauroxil, a novel once-monthly, long-acting injectable atypical antipsychotic, following deltoid and gluteal administration in adult subjects with schizophrenia.
    Turncliff R; Hard M; Du Y; Risinger R; Ehrich EW
    Schizophr Res; 2014 Nov; 159(2-3):404-10. PubMed ID: 25266547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the addition of aripiprazole on hyperprolactinemia associated with risperidone long-acting injection.
    Ziadi Trives M; Bonete Llácer JM; García Escudero MA; Martínez Pastor CJ
    J Clin Psychopharmacol; 2013 Aug; 33(4):538-41. PubMed ID: 23775053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
    Duvvuri S; Janoria KG; Pal D; Mitra AK
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A sensitive column-switching HPLC method for aripiprazole and dehydroaripiprazole and its application to human pharmacokinetic studies.
    Akamine Y; Yasui-Furukori N; Kojima M; Inoue Y; Uno T
    J Sep Sci; 2010 Nov; 33(21):3292-8. PubMed ID: 21049519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the recent antipsychotic aripiprazole in human plasma by capillary electrophoresis and high-performance liquid chromatography with diode array detection.
    Musenga A; Saracino MA; Spinelli D; Rizzato E; Boncompagni G; Kenndler E; Raggi MA
    Anal Chim Acta; 2008 Apr; 612(2):204-11. PubMed ID: 18358867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-acting injectable aripiprazole (Abilify Maintena) for schizophrenia.
    Med Lett Drugs Ther; 2013 Apr; 55(1415):34-6. PubMed ID: 23836344
    [No Abstract]   [Full Text] [Related]  

  • 17. Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb Pro: formulation aspects and nanoparticle stability to nebulization.
    Beck-Broichsitter M; Kleimann P; Gessler T; Seeger W; Kissel T; Schmehl T
    Int J Pharm; 2012 Jan; 422(1-2):398-408. PubMed ID: 22001839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of formulation parameters on encapsulation efficiency and release behavior of thienorphine loaded PLGA microspheres.
    Yang Y; Gao Y; Mei X
    Pharm Dev Technol; 2013; 18(5):1169-74. PubMed ID: 21967467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic study on the unique dimeric arylpiperazine: access to the minor contaminant of aripiprazole.
    Torisawa Y; Shinhama K; Nishi T; Minamikawa J
    Bioorg Med Chem Lett; 2003 Jan; 13(1):65-8. PubMed ID: 12467618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of aripiprazole for the treatment of schizophrenia: what dose is required?].
    Charpeaud T; Samalin L; Llorca PM
    Encephale; 2014 Feb; 40(1):62-73. PubMed ID: 24445245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.